A Chinese institutional note highlights major brain-computer interface (BCI) milestones, including Nobel Prize recognition for optogenetics, commercial sales of an invasive BCI, and positive clinical trial results.
BCI technology is hitting inflection points, with commercial sales and clinical validation driving a bullish outlook for Chinese medtech players.
Free preview — more China A-share & HK research · About Us · Legal & Privacy